— Paid Advertisement –

You know I love a good catalyst event when I am trading penny and biotech stocks.

With the right catalyst, a company holds serious growth potential. A good chunk of my trading strategy centers around finding these catalyst events and capitalizing on them.

Today, I want to share a different catalyst event with you.

It’s not for a penny stock… but for something potentially much bigger. And, likely penny stocks its no doubt risky.

You see, RagingBull as a group is always on the lookout for new angel investments to support in hopes of finding those “grand slams” that occur when you’re on the ground floor of the right one. 

That’s why the Boardroom invested in the Google startup, This Way.

We’ve got huge expectations for this company on the heels of a catalyst event that they recently announced: a new partnership with IBM that they revealed on Bloomberg TV.

They’re taking investors right now, and demand is heavy… to the point where they’ve almost sold out of their current funding round.

But…

If you’re reading this, that means there’s still a chance for you to jump in on this.

A partnership with IBM is definitely the kind of catalyst event that grabs my attention. And on top of that, it’s a Google-accelerated startup with 5000+ fresh customers.

If you want to learn more about Thisway and the perks of investing in them right now, watch this quick video breaking it down so you can see for yourself.

We’re in already – it’s your turn. Will you join us? 

Click HERE to watch the video.

RagingBull.com, LLC’s Issuer-Paid Advertisement Disclaimer and Disclosure policy

Issuer-paid advertisements. RagingBull.com, LLC (“Raging Bull”) may disseminate issuer-paid advertisements to enhance public awareness of the issuer’s company through Raging Bull’s paid and no-cost subscriber services in the form of emails, videos, and webpages (“Advertisements”). For any such Advertisements, Raging Bull will disclose the amount and type of compensation paid to Raging Bull to disseminate the Advertisements and whether Raging Bull is invested in the profiled company.

Raging Bull Is Not an Investment Advisor or Registered Broker. Neither Raging Bull nor any of its owners, employees OR INDEPENDENT CONTRACTORS is CURRENTLY registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

For Educational and Informational Purposes Only; Not Investment Advice. The Advertisements are for educational and informational purposes only. All material information contained in the Advertisements is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull cannot guarantee the accuracy or completeness of the information. The advertisements do not purport to be a complete analysis of any company’s financial position. The Advertisements or any statements made in them are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in the Advertisements should NOT be relied upon for purposes of investing in the companies mentioned in the Advertisements, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in the Advertisements or in any other security or strategy.

SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in the Advertisements should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Investing in the private companies discussed in this Advertisements is highly risky. There is currently no market for trading or liquidating the securities discussed in these Advertisements and there is no guarantee that a market will develop in the future. Readers of any Advertisements bear responsibility for their own investment research and decisions and should use information from the Advertisements only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money INVESTING OR trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in the Advertisements may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https://www.sec.gov/edgar/searchedgar/companysearch.html.

TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the Advertisements is made or implied.

Raging Bull Is Not an Investment Advisor or Registered Broker. Neither Raging Bull nor any of its owners, employees OR INDEPENDENT CONTRACTORS is CURRENTLY registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

For Educational and Informational Purposes Only; Not Investment Advice. The Advertisements are for educational and informational purposes only. All material information contained in the Advertisements is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull cannot guarantee the accuracy or completeness of the information. The advertisements do not purport to be a complete analysis of any company’s financial position. The Advertisements or any statements made in them are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in the Advertisements should NOT be relied upon for purposes of investing in the companies mentioned in the Advertisements, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in the Advertisements or in any other security or strategy.

SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in the Advertisements should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Investing in the private companies discussed in this Advertisements is highly risky. There is currently no market for trading or liquidating the securities discussed in these Advertisements and there is no guarantee that a market will develop in the future. Readers of any Advertisements bear responsibility for their own investment research and decisions and should use information from the Advertisements only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money INVESTING OR trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in the Advertisements may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https://www.sec.gov/edgar/searchedgar/companysearch.html.

TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the Advertisements is made or implied.

Preparation is vital in this game, and that’s why I always start the week off with a Biotech Breakouts Weekly Watch list for my members.

I provide an overview of the biotech and pharma space and then drill down into specific setups that I am watching for the week ahead.

Ever wondered what goes on my Biotech Breakout Weekly Watch List?

What do I find valuable and necessary to include?

How do I lay out my game plan?

Well, wonder no more.

It all starts with a game plan and weekly watch list, as my members know. 

Then, throughout the week, I will provide multiple updates daily, advanced notice alerts, video recaps, and more.

But it all starts with a Weekly Watch List, and I want to give you a taste of what my Watch Lists include:

Step 1: Where are we now? Where have we come from? Where are we going?

I always start by taking a close look at the XBI.

I do this by analyzing the previous week’s performance, noting where it is trading relative to the bigger picture, and what I would like to see going forward to give me added confidence.

Step 2: Biotech Stocks in the news

I like to keep recent movers that had a catalyst on my radar in case they provide secondary moves or further opportunities.

For example, in my most recent Watch List, I included these three stocks under this section:

Step 3: Biotech Stocks with near term catalysts + game plan

Then comes the juicy bit.

Under this section, I outline biotech and pharma stocks that met specific scan criteria to earn a spot on my watch list.

I drill down into the specifics in this section and typically cover around four stocks, although sometimes I will include more or less depending on the scan and opportunity.

For each stock, I outline:

• Upcoming and recent news/catalysts
• My game plan
• Overview of critical stats (cash burn, months of cash left, earnings date, rev guidance, and more)

Starting the week off with a detailed watch list and plan gives the added confidence and hunger to attack the markets prepared and without hesitation.

If you want to receive my detailed Weekly Watch List, and see what and why I have my eyes on for the week, click here to become a member of the Biotech Breakouts community.

Happy Friday!

I know, I know, it’s not Friday.

Friendly reminder: tomorrow is Good Friday, and the stock market will be CLOSED.

The market might be closed tomorrow, but the teaching never stops. So to my members, keep an eye out for exclusive content because I won’t leave you hanging tomorrow. 

I often talk about how much I love trading small-cap biotech stocks.

The upcoming catalysts, the volatility, and potential outlier moves are just a few reasons I love them so much.

It’s not all sunshine and rainbows, though, gang.

The intraday offering announced yesterday in LIXT is a prime example of a risk of trading small-cap biotech stocks.

LIXT shares rose higher in the morning after the company announced promising preclinical data. 

With the positive news and pullback from the pre-market high into the opening bell, I got long for a momentum move higher at $2.52.

I sold shortly after at $2.73 for an 8.33% win.

While I had a long trade in the stock, I voiced my concern to my members LIVE on camera in the chatroom.

And this leads me to…

How I Avoided Getting Stuck Long into An Offering

Shortly after closing my long position, I told my members that I wouldn’t look to hold a position for too long or even rebuy because I believe this stock has enormous offering potential.

By doing some digging into the company on biopharmcatalyst.com, I mentioned live on camera that this company had a small number of months left of cash (before the offering), a high burn rate, and dilution readily available. 

This led me to believe that LIXT might look to take advantage of the higher gap and increased liquidity to announce an offering.

I also saw on the SEC website that the company already has dilution in EFFECT by way of an ATM (At-the-Market) offering, and they still had an effective shelf that they could tap.

And lone-behold, the company announced an offering during the session yesterday, which caused the stock to plunge lower.

The Bottom Line

When it comes to small-cap biotech stocks, understanding the risks involved in trading or investing in them is essential.

The offering risk is one of them, and a big one, in my opinion.

As a result, I often speak to my Biotech Breakout members about key concepts and terms relating to offerings.

I’m certainly more proud that I could point out the potential for an offering versus the long trade I made in the stock because understanding the fundamentals potentially saved me $$.